- Home
- CRBG vs WAT Comparison
CRBG vs WAT Comparison
Compare CRBG & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBG
- WAT
- Stock Information
- Founded
- CRBG 1957
- WAT 1958
- Country
- CRBG United States
- WAT United States
- Employees
- CRBG N/A
- WAT N/A
- Industry
- CRBG Life Insurance
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- CRBG Finance
- WAT Industrials
- Exchange
- CRBG Nasdaq
- WAT Nasdaq
- Market Cap
- CRBG 18.9B
- WAT 20.1B
- IPO Year
- CRBG 2022
- WAT 1995
- Fundamental
- Price
- CRBG $31.13
- WAT $344.39
- Analyst Decision
- CRBG Buy
- WAT Buy
- Analyst Count
- CRBG 14
- WAT 15
- Target Price
- CRBG $37.07
- WAT $387.60
- AVG Volume (30 Days)
- CRBG 2.9M
- WAT 489.8K
- Earning Date
- CRBG 05-05-2025
- WAT 05-06-2025
- Dividend Yield
- CRBG 3.09%
- WAT N/A
- EPS Growth
- CRBG N/A
- WAT 8.23
- EPS
- CRBG 1.17
- WAT 11.02
- Revenue
- CRBG $16,561,000,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- CRBG $18.10
- WAT $5.16
- Revenue Next Year
- CRBG $5.57
- WAT $6.59
- P/E Ratio
- CRBG $26.47
- WAT $31.38
- Revenue Growth
- CRBG N/A
- WAT 2.57
- 52 Week Low
- CRBG $23.69
- WAT $279.24
- 52 Week High
- CRBG $35.36
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- CRBG 57.91
- WAT 54.04
- Support Level
- CRBG $30.03
- WAT $328.79
- Resistance Level
- CRBG $31.80
- WAT $358.29
- Average True Range (ATR)
- CRBG 0.89
- WAT 11.77
- MACD
- CRBG 0.36
- WAT 3.12
- Stochastic Oscillator
- CRBG 79.78
- WAT 83.65
About CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments namely Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.